Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAPTOP
2018-003481-13Phase 3Unknown
- Sponsor
- NEAT ID Foundation
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Human immunodeficiency virus infection type 1 comparing Biktarvy arm with Symtuza arm (2 arms). Status: unknown.
02
Drugs
bictegravir + emtricitabine + tenofovir alafenamidetenofovir alafenamide
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2018-003481-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003481-13.